Analysts think CLGN stock price could increase by 685%
May 12, 2025, 11:25 AM
-2.75%
What does CLGN do
CollPlant Biotechnologies specializes in regenerative and aesthetic medicine, offering products for tissue regeneration and organ production. Their technology relies on plant-based production of collagen type I (rhCollagen).
3 analysts think CLGN stock price will increase by 684.62%. The current median analyst target is $14.28 compared to a current stock price of $1.82. The lowest analysts target is $14.14 and the highest analyst target is $14.70.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
